The protein composition of the nuclear matrix of murine P19 embryonal carcinoma cells is differentiation-stage dependent.
The protein composition of the nuclear matrix of murine P19 embryonal carcinoma (EC) cells was compared with that of clonal derivatives of P19 EC differentiated in vitro, and with that of P19 EC cells induced to differentiate with retinoic acid (RA). Several major differences in nuclear matrix protein composition were found between the cell lines tested. Some polypeptides were found to occur only in EC cells, whereas others proved to be restricted to one or more of the differentiated derivatives. During RA treatment of EC cells a transient expression of some matrix proteins was observed. Several new proteins appeared, and others disappeared. Our data indicate that the protein composition of the nuclear matrix is a sensitive gauge for the differentiation state of cells.
Stuurman
N
N
Laboratory of Biochemistry, University of Amsterdam, The Netherlands.
Van Driel
R
R
De Jong
L
L
Meijne
A M
AM
Van Renswoude
J
J
D000818:Animals; D034961:Antigens, Nuclear; D002454:Cell Differentiation / Q000187:drug effects; D002467:Cell Nucleus / Q000032:analysis / Q000187:drug effects / Q000473:pathology; D002999:Clone Cells / Q000032:analysis / Q000187:drug effects / Q000473:pathology; D054278:Embryonal Carcinoma Stem Cells; D051379:Mice; D014411:Neoplastic Stem Cells / Q000032:analysis* / Q000187:drug effects / Q000473:pathology; D009687:Nuclear Proteins / Q000302:isolation & purification* / Q000502:physiology; D014212:Tretinoin
D034961:Antigens, Nuclear; D009687:Nuclear Proteins; D014212:Tretinoin